| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.02B | 11.80B | 12.15B | 11.91B | 11.03B | 9.33B |
| Gross Profit | 2.37B | 2.29B | 2.19B | 2.43B | 2.41B | 1.97B |
| EBITDA | 907.37M | 857.48M | 988.02M | 1.11B | 1.22B | 987.78M |
| Net Income | 298.28M | 260.93M | 245.84M | 434.84M | 548.68M | 327.14M |
Balance Sheet | ||||||
| Total Assets | 17.75B | 17.93B | 18.10B | 17.34B | 16.85B | 16.21B |
| Cash, Cash Equivalents and Short-Term Investments | 3.42B | 3.44B | 2.91B | 2.09B | 2.66B | 2.29B |
| Total Debt | 1.73B | 1.99B | 2.00B | 1.25B | 1.17B | 1.37B |
| Total Liabilities | 5.59B | 5.60B | 6.01B | 5.51B | 5.34B | 5.03B |
| Stockholders Equity | 11.58B | 11.72B | 11.50B | 11.34B | 11.06B | 10.76B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 807.60M | -2.78M | -368.21M | 386.46M | 615.33M |
| Operating Cash Flow | 0.00 | 1.12B | 956.97M | 510.53M | 676.61M | 787.30M |
| Investing Cash Flow | 0.00 | -480.51M | -592.18M | -967.10M | 209.41M | -155.01M |
| Financing Cash Flow | 0.00 | -172.50M | 417.89M | -197.45M | -528.04M | -49.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥25.96B | 13.22 | ― | 3.89% | 1.33% | 29.73% | |
77 Outperform | ¥21.74B | 14.20 | ― | 3.31% | 0.97% | -10.47% | |
76 Outperform | ¥17.56B | 24.91 | 3.00% | 1.28% | 2.25% | 42.58% | |
76 Outperform | ¥252.23B | 24.11 | ― | 1.17% | 29.51% | 48.81% | |
72 Outperform | ¥238.44B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥115.71B | 17.03 | 2.64% | 2.30% | -4.11% | 46.76% |